RJA
CDMO

Raymond James & Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Raymond James & Associates’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$115K Hold
10,100
– – ﹤0.01% 3767
2024
Q2 		$72.1K Hold
10,100
– – ﹤0.01% 3763
2024
Q1 		$67.7K Sell
10,100
-38
-0.4% -$261 ﹤0.01% 3774
2023
Q4 		$65.9K Sell
10,138
-944
-9% -$6.08K ﹤0.01% 3682
2023
Q3 		$105K Sell
11,082
-2,972
-21% -$35.8K ﹤0.01% 3591
2023
Q2 		$196K Sell
14,054
-327
-2% -$5.57K ﹤0.01% 3491
2023
Q1 		$270K Hold
14,381
– – ﹤0.01% 3306
2022
Q4 		$198K Hold
14,381
– – ﹤0.01% 3457
2022
Q3 		$275K Hold
14,381
– – ﹤0.01% 3242
2022
Q2 		$219K Hold
14,381
– – ﹤0.01% 3448
2022
Q1 		$293K Hold
14,381
– – ﹤0.01% 3433
2021
Q4 		$420K Buy
14,381
+3,972
+38% +$114K ﹤0.01% 3221
2021
Q3 		$225K Hold
10,409
– – ﹤0.01% 3601
2021
Q2 		$267K Hold
10,409
– – ﹤0.01% 3515
2021
Q1 		$190K Sell
10,409
-58
-0.6% -$964 ﹤0.01% 3629
2020
Q4 		$121K Hold
10,467
– – ﹤0.01% 3526
2020
Q3 		$80K Sell
10,467
-9
-0.1% -$68 ﹤0.01% 3408
2020
Q2 		$69K Buy
10,476
+9
+0.1% +$50 ﹤0.01% 3344
2020
Q1 		$53K Buy
+10,467
New +$63.3K ﹤0.01% 3310
2017
Q1 		– Sell
-2,937
Closed -$6K – 3417
2016
Q4 		$6K Hold
2,937
– – ﹤0.01% 3208
2016
Q3 		$9K Sell
2,937
-428
-13% -$1.15K ﹤0.01% 3175
2016
Q2 		$9K Sell
3,365
-214
-6% -$596 ﹤0.01% 2971
2016
Q1 		$11K Buy
+3,579
New +$19.2K ﹤0.01% 2886

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Raymond James & Associates's CDMO Position: Q3 2024 in Review

Raymond James & Associates held its Avid Bioservices, Inc. Common Stock (CDMO) position steady in Q3 2024 at 10,100 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

Raymond James & Associates first reported a position in CDMO in Q1 2016 and has held it in 23 quarters since. The position peaked at $420K in Q4 2021. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • Raymond James & Associates held 10,100 shares of Avid Bioservices, Inc. Common Stock worth $115K as of Q3 2024.
  • Raymond James & Associates left its Avid Bioservices, Inc. Common Stock share count unchanged in Q3 2024.
  • Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3767 holding.
  • Raymond James & Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2016 and has held it in 23 quarters since.
  • Raymond James & Associates's Avid Bioservices, Inc. Common Stock position peaked at $420K in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.